Our current offers: 

FASTest® TOXOPLASMA g

FASTest® TOXOPLASMA g

Field of application:
FASTest® TOXOPLASMA
g is a rapid immunochromatographic test for the qualitative detection of antibodies against Toxoplasma gondii in whole blood, plasma or serum of the cat and dog.

Introduction:
Toxoplasmosis is caused by the protozoon Toxoplasma gondii. It plays an important epidemiologic role especially in the cat, but also in the dog. Other mammals, humans (zoonosis) and birds can be infected as intermediate hosts with T. gondii oocysts world-wide.

(more)

MegaELISA® EHRLICHIA canis

MegaELISA® EHRLICHIA canis

Field of application:
MegaELISA® EHRLICHIA
canis is an enzyme immunoassay for the qualitative detection of IgG antibodies against Ehrlichia canis in plasma or serum of the dog.

Introduction:
Canine monocytic ehrlichiosis (CME) is caused by the rickettsia Ehrlichia canis, which are mainly transmitted by the brown dog tick (Rhipicephalus sanguineus). Ehrlichia canis is found in many parts of the world, especially in the Mediterranean area, but also in Switzerland and partly Germany.

(more)

MegaBLOT® LYME IgG

MegaBLOT® LYME IgG

Field of application:
MegaBLOT® LYME IgG
is a LINE immunoassay for the qualitative detection of specific IgG antibodies against Borrelia burgdorferi sensu lato in plasma or serum of the dog.

The LINE Blot Strip has been coated with specific recombinant Borrelia antigens which are applied to defined test line positions on the membrane. Therefore, the test lines appearing during the test can be compared to the Cut-off Control. Because the reading has been standardised, the test can now be read easier and the interpretation is safer.

Introduction:
Borreliosis caused by the borrelia species Borrelia burgdorferi sensu lato (B.b.s.l., genospecies B.b. sensu stricto, B. garinii, B. afzelii) is a world-wide spread infectious disease in dogs, other animals and in humans. Ticks that transmit Borrelia (Ixodes ricinus, castor bean tick) are infected up to 30% with Borrelia. In dogs from endemic areas, the antibody prevalence (up to 95%) correlates with dog ownership, dog’s outdoor time and sucking time of the ticks.

(more)

TiterCHEK® CDV/CPV

TiterCHEK® CDV/CPV

Field of application:

TiterCHEK® CDV/CPV is an enzyme immunoassay (ELISA) for the qualitative determination of the CDV (Canine Distempervirus) and CPV (Canine Parvovirus) antibody status in the plasma or serum of the dog.

Introduction:
Antibodies are basic modules of the humoral immune response. They are passed by passively via the colostrum as so-called maternal antibodies (mAb) onto the yet immunoincompetent newborns or induced actively by natural field infection or vaccination. The antibody titre is varying individually in each animal, depending on multiple factors. It can persist over an extended period of time, partially lifelong, in efficient protection concentration (= reliable immunity by protective antibodies) or can fall below the efficient protection concentration (non-reliable immunity) in the course of time.

Canine Distempervirus (CDV) as well as Canine Parvovirus (CPV) both are dreaded viral infectious agents throughout the world. While Distemper manifests in various forms (gastrointestinal, respiratory, cutaneous or nervous), Parvovirus causes viral gastro enteritis (severe diarrhoea, vomiting, anorexia, dehydration and panleukopenia) in the dog. The mortality rate, especially in non-vaccinated dogs, is high for both virus diseases.

The examination of the antibody titre against Distemper and Parvovirosis before booster vaccination is recommended due to WSAVA and StIKo guidelines. The determination of the actual CDV and CPV IgG antibody titre is an important diagnostic parameter for the estimation of the individual protective CDV and CPV IgG immune status. Dependent on the amount of the individual antibody titre of breeding bitch and puppies, after performance of TiterCHEK® CDV/CPV the veterinarian is able to make a fast and reliable decision concerning the need to vaccinate or not.

• In puppies, there is a critical stage (so-called immunity gap), especially in the first 12–16 weeks. During this stage the concentration of mAb could be high enough to inactivate the vaccinating virus but also too low to protect from field infection. Therefore it is important to find the individual primary vaccination point for each puppy to guarantee an appropriate protection.

• By determination of the actual antibody status, an individual decision of the necessity of booster vaccination of the puppy or the adult animal can be made.

Being fast, safe and reliable, for pet owner and breeder these important questions can be answered practically by TiterCHEK® CDV/CPV. This enables the veterinarian an appropriate and customized vaccination diagnostics and strategy, adapted to dog and pet owner.

(more)

01.08.2016

New MYKODERMOASSAY for dog and cat

MYKODERMOASSAY MALASSEZIA (more)


13.07.2016

New: FASTest® C. perfringens

Diarrhoea pathogen with high enterotoxic potential (more)

We exhibit

12.05. - 13.05.2017

Deutsche Vet Köln (more)


16.09. - 17.09.2017

32. VÖK-Jahrestagung, Salzburg (more)

In-Clinic Test Results with laboratory precision